As drug maker Allergan Inc tries to avoid being acquired it is taking a page from its pursuer Valeant Pharmaceuticals International Inc The Botox maker said Monday it is laying off workers and cutting drug researchexactly what Valeant said it would do if it acquired Allerganas it tries to convince investors its capable alone of delivering strong earnings growth The layoffs will represent  of Allergans workforce the Irvine Califbased company said Monday adding that it will also discontinue some earlystage
  